图表:每一个斗权引渡的转折点

币界网Опубліковано о 2024-08-09Востаннє оновлено о 2024-08-09

币界网报道:

就在我们以为一切都结束的时候,黑山把我们拉了回来。据当地新闻媒体Vijesti报道,该国最高法院再次推迟了对Do Kwon的引渡。

法院昨日宣布,已推迟将他引渡到韩国的计划,并将根据最高国家检察官办公室的“保护合法性”请求,确定高等法院和上诉法院之前的裁决是否合法。

算上杜·权引渡过程中出现的各种逆转、延误、上诉、申请和批准,自去年11月以来,至少有20次来回。

在此期间,高等法院和上诉法院已两次批准将Do引渡到美国,四次批准将其引渡到韩国。判决已被推翻五次,杜已提交五次上诉。在这五次上诉中,他只输过一次。

普罗托斯制作了一张图表,详细说明了许多曲折。

阅读更多:黑山总理Milojko Spajić可能会见了Do Kwon,报道

Do Kwon律师称这是“司法耻辱”

Do的律师Goran Radić声称,司法部长Andrej Milović做出了将Do引渡到美国而不是韩国的“非法私人承诺”。他还称引渡程序是“司法耻辱”

今年2月,高等法院裁定美国首先提交了引渡请求,但上诉法院于3月5日作出反对裁决,称其没有考虑韩国早些时候提交的两封电子邮件。

在最近的事态发展中,高等法院于6月裁定,Do可以被引渡到韩国。Do没有对这一决定提出上诉,8月1日,上诉法院批准了这一决定。

阅读更多:权上诉律师在听证会前有20分钟的时间审查文件吗

最高法院可能会像4月5日那样将裁决发回高等法院重审。在此之前,黑山警方和司法部将不会引渡Do。

有消息吗?给我们发电子邮件或ProtonMail。如需了解更多信息,请在X、Instagram、Bluesky和谷歌新闻上关注我们,或订阅我们的YouTube频道。

Пов'язані матеріали

Stock Price Doubles Within the Year, Plummets 20% After Resumption, Baolai Medical's 'Chip Backdoor Listing' Script Ends

On August 10, 2026, BPL (300246.SZ) resumed trading after a nearly week-long suspension and immediately fell by a 20% limit-down. This plunge was triggered by the termination of a planned controlling stake transfer, dashing earlier market speculation. In January 2026, Zhejiang Quwei Zhihe Partnership entered as a significant shareholder, sparking hopes. Investors speculated that its backer, Weigu Information—a specialized "little giant" company in high-reliability solid-state storage chips—might be seeking a backdoor listing through BPL. This "cross-industry restructuring" expectation fueled a strong rally, with BPL's stock price more than doubling in 2026 prior to the halt. However, the deal was called off on August 7, directly causing the sharp sell-off. Underlying BPL's vulnerability is its fundamentally weak business. The company, a medical device firm, is mired in losses, having reported three consecutive years of net losses totaling over 200 million yuan. Its core hemodialysis business is squeezed by government procurement price cuts, while growth in its patient monitor segment has stalled. Furthermore, BPL faces imminent debt pressure with convertible bonds worth approximately 218 million yuan due in September 2026, and its current stock price is far below the conversion price. The failed control transfer may represent a delayed release of negative news, but BPL's core challenges remain: reversing operational losses and addressing its urgent liquidity crisis.

marsbit2 год тому

Stock Price Doubles Within the Year, Plummets 20% After Resumption, Baolai Medical's 'Chip Backdoor Listing' Script Ends

marsbit2 год тому

Торгівля

Спот
活动图片